Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Inflamm Bowel Dis. 2011 Feb 23;18(1):112–119. doi: 10.1002/ibd.21675

Figure 4.

Figure 4

Results of anti-BMP6 treatment of mice with T cell transfer colitis. A, Liver hepcidin mRNA levels in mice treated with vehicle or anti-BMP6, expressed relative to the mean level in vehicle-treated mice. *p = 0.047, n = 4 mice in the vehicle-treated group, 5 in the anti-BMP6 group. B, Colon IL-17 mRNA levels in the middle and distal regions of the colon of mice treated with vehicle or anti-BMP6, expressed relative to the mean level in the vehicle-treated group. *p = 0.021, n = 4 mice in the vehicle-treated group, 5 in the anti-BMP6 group. C, Serum iron concentrations in mice treated with vehicle or anti-BMP6. *p = 0.043, n = 4 mice in the vehicle-treated group, 5 in the anti-BMP6 group.